Cutting Edge: A Critical Role for IL-10 in Induction of Nasal Tolerance in Experimental Autoimmune Myocarditis
- 15 February 2002
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 168 (4) , 1552-1556
- https://doi.org/10.4049/jimmunol.168.4.1552
Abstract
Appropriate treatment of autoimmune myocarditis following virus infection remains a major clinical problem. Induction of nasal tolerance may provide a new approach to treatment. However, the exact mechanism of nasal tolerance is unknown. To assess the mechanism of nasal tolerance, we examined the role of IL-10 in the induction and suppression of autoimmune myocarditis. First we showed that blocking IL-10 concurrent with nasal administration of Ag abolished the disease-suppressing effect of nasal tolerization. It also led to increased cardiac myosin-specific IL-1 and TNF-α production. Then we demonstrated that blocking IL-10 during the effector phase increased not only the incidence and severity of disease but also Ag-specific IL-2, IL-4, and TNF-α production as well as cardiac myosin-specific IgG1 and IgG2b production, whereas blocking IL-10 during the induction phase had no effect. This study implicates IL-10 in the induction of nasal tolerance and in limiting inflammation later during the disease process.Keywords
This publication has 29 references indexed in Scilit:
- Experimental Autoimmune Myocarditis in A/J mice Is an Interleukin-4-Dependent Disease with a Th2 PhenotypeThe American Journal of Pathology, 2001
- Interleukin-10 and the Interleukin-10 ReceptorAnnual Review of Immunology, 2001
- Interleukin 10 aggravates experimental autoimmune myasthenia gravis through inducing Th2 and B cell responses to AChRJournal of Neuroimmunology, 2001
- Induction of oral tolerance to the acetylcholine receptor for treatment of myasthenia gravisJournal of Clinical Investigation, 1999
- Suppression of Collagen-induced Arthritis by Oral or Nasal Administration of Type II CollagenJournal of Autoimmunity, 1999
- Characterization of Cytokine and iNOS mRNA Expression in situ During the Course of Experimental Autoimmune Myocarditis in RatsJournal of Molecular and Cellular Cardiology, 1997
- Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes.The Journal of Experimental Medicine, 1996
- A Clinical Trial of Immunosuppressive Therapy for MyocarditisNew England Journal of Medicine, 1995
- Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptorJournal of Neuroimmunology, 1995
- Viral Myocarditis Leading to Cardiomyopathy: Do Cytokines Contribute to Pathogenesis?Clinical Immunology and Immunopathology, 1993